MX9200017A - Antibioticos de 1-carba(1-destia)cefalosporina y metodo para su preparacion. - Google Patents
Antibioticos de 1-carba(1-destia)cefalosporina y metodo para su preparacion.Info
- Publication number
- MX9200017A MX9200017A MX9200017A MX9200017A MX9200017A MX 9200017 A MX9200017 A MX 9200017A MX 9200017 A MX9200017 A MX 9200017A MX 9200017 A MX9200017 A MX 9200017A MX 9200017 A MX9200017 A MX 9200017A
- Authority
- MX
- Mexico
- Prior art keywords
- destia
- carba
- cephalosporin
- antibiotics
- preparation
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 150000001780 cephalosporins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/639,475 US5099015A (en) | 1991-01-10 | 1991-01-10 | Trifluoromethyl 1-carba(1-dethia)cephems |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9200017A true MX9200017A (es) | 1992-07-01 |
Family
ID=24564249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9200017A MX9200017A (es) | 1991-01-10 | 1992-01-03 | Antibioticos de 1-carba(1-destia)cefalosporina y metodo para su preparacion. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5099015A (es) |
| EP (1) | EP0494733A1 (es) |
| JP (1) | JPH05140160A (es) |
| KR (1) | KR920014809A (es) |
| CN (1) | CN1063104A (es) |
| AU (1) | AU640072B2 (es) |
| BR (1) | BR9200004A (es) |
| CA (1) | CA2058699A1 (es) |
| CS (1) | CS792A3 (es) |
| FI (1) | FI920019A (es) |
| HU (1) | HUT60267A (es) |
| IE (1) | IE920021A1 (es) |
| IL (1) | IL100573A (es) |
| MX (1) | MX9200017A (es) |
| NO (1) | NO920050L (es) |
| NZ (1) | NZ241160A (es) |
| PT (1) | PT99969A (es) |
| RU (1) | RU2089551C1 (es) |
| TW (1) | TW213912B (es) |
| YU (1) | YU200791A (es) |
| ZA (1) | ZA9222B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9305837D0 (en) * | 1993-03-20 | 1993-05-05 | Smithkline Beecham Plc | Novel compounds |
| US5525599A (en) * | 1993-07-21 | 1996-06-11 | Eli Lilly And Company | 7-substituted-amino-3-substituted-3-cephem-4-carboxylic acids |
| US20050245498A1 (en) * | 2002-05-14 | 2005-11-03 | Shoichet Brian K | Sterically-awkward beta-lactamase inhibitors |
| US20030236243A1 (en) * | 2002-05-14 | 2003-12-25 | Shoichet Brian K. | Sterically-awkward beta-lactamase inhibitors |
| WO2007034924A1 (ja) * | 2005-09-22 | 2007-03-29 | Meiji Seika Kaisha, Ltd. | メタロ－β－ラクタマーゼ阻害剤 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4347367A (en) * | 1977-10-19 | 1982-08-31 | Merck & Co., Inc. | 3-Substituted-6-(1'-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid |
| NO155547C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling. |
| NO802713L (no) * | 1979-09-13 | 1981-03-16 | Kyowa Hakko Kogyo Kk | Fremgangsmaate til fremstilling av racemiske eller optisk aktive cefalosporin-analoge karbacefemforbindelser eller farmaseutisk akseptable salter derav |
| JPS5842860B2 (ja) * | 1979-10-12 | 1983-09-22 | 三菱瓦斯化学株式会社 | ２−ペンテン酸エステルの製造方法 |
| DK389180A (da) * | 1979-10-25 | 1981-04-26 | Kyowa Hakko Kogyo Kk | Optisk aktive cephalosporin-analoge carbacephemforbindelser og salte deraf samt fremgangsmaade til fremstilling deraf |
| JPS5849382A (ja) * | 1981-09-18 | 1983-03-23 | Kyowa Hakko Kogyo Co Ltd | β−ラクタム化合物 |
| JPS60174787A (ja) * | 1984-02-21 | 1985-09-09 | Kyowa Hakko Kogyo Co Ltd | ３位置換カルバセフエム化合物 |
| US4673737A (en) * | 1985-08-02 | 1987-06-16 | Harvard University | 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof |
| US4708956A (en) * | 1985-12-12 | 1987-11-24 | Kyowa Hakko Kogyo Co., Ltd. | 3-position halogenated cephalosporin analogs and pharmaceutical compositions |
| DE3880229T2 (de) * | 1987-07-31 | 1993-08-12 | Lilly Co Eli | Verfahren zum entschuetzen von 3-aminoazetidinonen. |
| DE3803169A1 (de) * | 1988-02-03 | 1989-08-17 | Bayer Ag | Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln |
-
1991
- 1991-01-10 US US07/639,475 patent/US5099015A/en not_active Expired - Fee Related
- 1991-12-23 NZ NZ241160A patent/NZ241160A/en unknown
- 1991-12-27 JP JP3360564A patent/JPH05140160A/ja not_active Withdrawn
- 1991-12-30 YU YU200791A patent/YU200791A/sh unknown
-
1992
- 1992-01-01 IL IL10057392A patent/IL100573A/xx not_active IP Right Cessation
- 1992-01-02 CA CA002058699A patent/CA2058699A1/en not_active Abandoned
- 1992-01-02 ZA ZA9222A patent/ZA9222B/xx unknown
- 1992-01-02 AU AU10011/92A patent/AU640072B2/en not_active Ceased
- 1992-01-02 CS CS927A patent/CS792A3/cs unknown
- 1992-01-02 PT PT99969A patent/PT99969A/pt not_active Application Discontinuation
- 1992-01-02 HU HU9200011A patent/HUT60267A/hu unknown
- 1992-01-02 BR BR929200004A patent/BR9200004A/pt not_active Application Discontinuation
- 1992-01-02 FI FI920019A patent/FI920019A/fi not_active Application Discontinuation
- 1992-01-03 CN CN92100039A patent/CN1063104A/zh active Pending
- 1992-01-03 TW TW081100001A patent/TW213912B/zh active
- 1992-01-03 KR KR1019920000009A patent/KR920014809A/ko not_active Application Discontinuation
- 1992-01-03 MX MX9200017A patent/MX9200017A/es unknown
- 1992-01-03 NO NO92920050A patent/NO920050L/no unknown
- 1992-01-03 RU SU925010586A patent/RU2089551C1/ru active
- 1992-01-03 IE IE002192A patent/IE920021A1/en unknown
- 1992-01-03 EP EP92300040A patent/EP0494733A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US5099015A (en) | 1992-03-24 |
| AU640072B2 (en) | 1993-08-12 |
| FI920019A0 (fi) | 1992-01-02 |
| ZA9222B (en) | 1993-07-02 |
| CA2058699A1 (en) | 1992-07-11 |
| BR9200004A (pt) | 1992-09-08 |
| IL100573A (en) | 1997-01-10 |
| NZ241160A (en) | 1994-04-27 |
| NO920050D0 (no) | 1992-01-03 |
| JPH05140160A (ja) | 1993-06-08 |
| TW213912B (es) | 1993-10-01 |
| IE920021A1 (en) | 1992-07-15 |
| PT99969A (pt) | 1993-02-26 |
| HUT60267A (en) | 1992-08-28 |
| HU9200011D0 (en) | 1992-03-30 |
| KR920014809A (ko) | 1992-08-25 |
| NO920050L (no) | 1992-07-13 |
| IL100573A0 (en) | 1992-09-06 |
| CN1063104A (zh) | 1992-07-29 |
| FI920019A (fi) | 1992-07-11 |
| EP0494733A1 (en) | 1992-07-15 |
| YU200791A (sh) | 1994-01-20 |
| AU1001192A (en) | 1992-07-16 |
| CS792A3 (en) | 1992-07-15 |
| RU2089551C1 (ru) | 1997-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9202290A (es) | Nuevos derivados de tiopiranopirrol y procedimiento para su preparacion. | |
| AU9040491A (en) | Method for the isolation and purification of taxane derivatives | |
| MX9206628A (es) | Ester de prolinaboronato y metodo para su preparacion. | |
| MX20359A (es) | Derivados de 2-oxindol 3-substituidos. | |
| FI930474A0 (fi) | Antibiotiska foereningar | |
| NO964139D0 (no) | Cefalosporinantibiotika | |
| MX9201355A (es) | Bis-naftal imidas y metodo para su preparacion. | |
| MX9202022A (es) | Derivados de pirazina y proceso para su preparacion. | |
| MX9202281A (es) | Derivados de benzofurano y procedimiento para su preparacion. | |
| AU3345193A (en) | An improved method for the preparation of certain beta-lactam antibiotics | |
| NO895160D0 (no) | Mikrobiell fremgangsmaate for fremstilling av immunhemmende antibiotika. | |
| MX9202402A (es) | Cuerpo de espuma de ceramica y metodo para su fabricacion. | |
| MX21917A (es) | Derivados de benzopirano y benzotiopirano y procedimiento para su preparacion. | |
| MX13277A (es) | Monohidrato cristalino de un antibiotico de beta-lactama y procedimiento para su preparacion. | |
| MX9203836A (es) | Derivados de acido-4-amino-3-hidroxicarboxilico y proceso para su preparacion. | |
| MX9200017A (es) | Antibioticos de 1-carba(1-destia)cefalosporina y metodo para su preparacion. | |
| MX9202536A (es) | Antibioticos tetraciclicos y procedimiento para su preparacion. | |
| MX9204370A (es) | Derivados de pirazol. | |
| MX9206777A (es) | Metodo para la elaboracion de cemento | |
| IT1181667B (it) | Antibiotici cefalosporinici e procedimento per la loro preparazione | |
| MX9201931A (es) | Nuevos derivados de tiazol. | |
| MX9201540A (es) | Derivados de amidina y proceso para su preparacion. | |
| AU629032B2 (en) | Letterpress for transferring and method of transferring by use of the letterpress for transferring | |
| MX17550A (es) | Compuestos de 1-carba(detia)cefalosporina y procedimiento para su preparacion. | |
| KR900011469A (ko) | 새로운 항생물질 n-아세틸베나노마이신 b 및 그 제조방법과 이의 용도 |